Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | -191,040 | 0 | 0 | 0 |
| Depreciation Amortization | 0 | 164,180 | 0 | 0 | 0 |
| Other Working Capital | 0 | -14,300 | 0 | 0 | 0 |
| Other Operating Activity | 0 | 276,220 | 0 | 0 | 0 |
| Operating Cash Flow | $0 | $235,060 | $0 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -50,440 | 0 | 0 | 0 |
| Net Acquisitions | 0 | -44,020 | 0 | 0 | 0 |
| Other Investing Activity | 0 | 324,270 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $229,810 | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -549,150 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $-549,150 | $0 | $0 | $0 |
| Exchange Rate Effect | 0 | 15,930 | 0 | 0 | 0 |
| Beginning Cash Position | 0 | 435,230 | 0 | 0 | 0 |
| End Cash Position | 0 | 366,890 | 0 | 0 | 0 |
| Net Cash Flow | $0 | $-68,330 | $0 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 235,060 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 235,060 | 0 | 0 | 0 |